![François M. Legault](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
François M. Legault
Director/Board Member at
Neurochem (International) Ltd.
Profile
François M.
Legault is currently the Director at Picchio Pharma, Inc. and the Director at Neurochem (International) Ltd. He previously served as the Chairman at Thallion Pharmaceuticals, Inc. from 2002 to 2010.
He also held positions as a Director at BELLUS Health, Inc., Ecopia BioSciences, Inc., Adaltis, Inc., and CellCarta Biosciences, Inc. Additionally, he was the Chief Financial Officer at Biochem Pharma, Inc. and the President & Chief Operating Officer at ViroChem Pharma, Inc.
François M. Legault active positions
| Companies | Position | Start |
|---|---|---|
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides licensing and partnering activities | Director/Board Member | 2010-01-19 |
Picchio Pharma, Inc.
 Picchio Pharma, Inc. Pharmaceuticals: GenericHealth Technology Engages in acquiring, developing, and commercializing new therapeutic products | Director/Board Member | - |
Former positions of François M. Legault
| Companies | Position | End |
|---|---|---|
| THALLION PHARMACEUTICALS INC. | Chairman | 2010-01-10 |
Adaltis, Inc.
 Adaltis, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets in-vitro diagnostic products | Director/Board Member | 2008-10-01 |
Ecopia BioSciences, Inc.
 Ecopia BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops anticancer therapies from soil-dwelling micro organisms | Director/Board Member | - |
Biochem Pharma, Inc.
 Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products focused on infectious diseases and cancer | Director of Finance/CFO | - |
| BELLUS HEALTH | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
40
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease | Health Technology |
Ecopia BioSciences, Inc.
Ecopia BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops anticancer therapies from soil-dwelling micro organisms | Health Technology |
Picchio Pharma, Inc.
Picchio Pharma, Inc. Pharmaceuticals: GenericHealth Technology Engages in acquiring, developing, and commercializing new therapeutic products | Health Technology |
Biochem Pharma, Inc.
Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products focused on infectious diseases and cancer | Health Technology |
Adaltis, Inc.
Adaltis, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets in-vitro diagnostic products | Health Technology |
ViroChem Pharma, Inc.
 ViroChem Pharma, Inc. Pharmaceuticals: MajorHealth Technology Provides antiviral drug research and development services | Health Technology |
Thallion Pharmaceuticals, Inc.
 Thallion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new pharmaceutical products | Health Technology |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as specialty contract research laboratory | Commercial Services |
Neurochem (International) Ltd.
Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides licensing and partnering activities | Commercial Services |
- Stock Market
- Insiders
- François M. Legault
